Annual report pursuant to Section 13 and 15(d)

Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details)

v3.22.0.1
Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Non-capital losses carried forward $ 17,596 $ 14,321
Research and development expenditures 817 817
Share issue costs 608 837
Patents and other 309 300
Accruals 76 6
Property and equipment (13) (14)
Total deferred tax asset, net 19,393 16,267
Valuation allowance (19,393) (16,267)
Net deferred tax asset $ 0 $ 0